This country profile provides an overview of the Congo’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage increased from 30% in 2018 to 52% in 2019.
Congo does not require mass treatment for blinding trachoma.
Treatment coverage increased from 43% in 2018 to 47% in 2019.
Treatment coverage decreased from 37% in 2018 to 0% in 2019.
Treatment coverage increased from 81% in 2018 to 82% in 2019.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Congo.